Skip to main content

EluRyng FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 14, 2020.

FDA Approved: Yes (First approved December 11, 2019)
Brand name: EluRyng
Generic name: ethinyl estradiol and etonogestrel
Dosage form: Vaginal Ring
Company: Amneal Pharmaceuticals LLC
Treatment for: Birth Control

EluRyng (ethinyl estradiol/etonogestrel vaginal ring) is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy.

EluRyng is the first approved generic version of NuvaRing.

Development timeline for EluRyng

Dec 12, 2019Approval FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.